UMediC Group Berhad (KLSE:UMC)

Malaysia · Delayed Price · Currency is MYR

0.2600

-0.0050 (-1.89%)

At close: Nov 2, 2026

Market Cap	97.22M -40.9%
Revenue (ttm)	58.69M +20.8%
Net Income	7.72M -5.1%
EPS	0.02 -5.3%
Shares Out	373.91M
PE Ratio	12.62
Forward PE	10.98
Dividend	0.01 (2.31%)
Ex-Dividend Date	Jan 29, 2026

Volume	30,100
Open	0.2700
Previous Close	0.2650
Day's Range	0.2600 - 0.2700
52-Week Range	0.2450 - 0.4400
Beta	0.23
Analysts	Buy
Price Target	0.36 (+39.73%)
Est. Earnings	Dec 4, 2026

About UMediC Group Berhad

UMediC Group Berhad, an investment holding company, develops, manufactures, markets, and distributes medical devices and consumables in Malaysia, the Asia Pacific, the Americas, Europe, the Middle East, Africa, and Oceania. The company operates nursing homes and healthcare centers, and other related services; markets and distributes laboratory equipment and consumables; and provides after-sales services. It also provides HYDROX prefilled humidifiers and nebulizers; AIRDROX inhaler spacers; FLEXIDROX water for inhalation bag; and hospital furnit... [Read more]

Industry Medical, Dental, and Hospital Equipment and Supplies

Founded 2021

Employees 166

Stock Exchange Bursa Malaysia

Ticker Symbol UMC

Full Company Profile

Financial Performance

In fiscal year 2026, UMediC Group Berhad's revenue was 58.69 million, an increase of 20.84% compared to the previous year's 48.56 million. Earnings were 7.72 million, a decrease of -5.15%.

Financial Statements

Analyst Summary

According to 3 analysts, the average rating for UMC stock is "Buy." The 12-month stock price target is RM 0.36, which is an increase of 39.73% from the latest price.

Price Target

RM 0.36

(39.73% upside)

Analyst Consensus: Buy

Stock Forecasts